On the evening of August 6, Unitree Robotics published its STAR Market (Sci-Tech Board) offering announcement, setting the IPO price at 150.80 yuan/share. With 40.446434 million shares offered (10% of post-issue total share capital), the issuance market capitalization is approximately 60.993 billion yuan. The subscription date is August 10 (online and offline simultaneously, ticker 688836), with payment due August 12 (T+2).
Several numbers behind the pricing deserve a closer look:
Valuation and Pricing
- Issuance P/E ratio of 219.23x, versus an industry average of 38.56x
- Total proceeds of about 6.099 billion yuan, net 5.917 billion yuan — a 45% overshoot versus the 4.202 billion yuan originally planned in the prospectus
- A one-year valuation leap: from 12.7 billion yuan in the final pre-IPO round (June 2025) to 61 billion yuan at issuance, an increase of ~48.3 billion yuan, or 3.8x
- Ten-year view: from a 13.33 million yuan seed-round valuation in 2016 to 61 billion yuan at issuance — a 4,573x increase
- Allocated 933,390 shares (2.31% of this offering), worth about 141 million yuan
- 36-month lock-up — the longest among all strategic investors
- Stated strategic intent in the announcement: "focus on AI large-model and embodied-intelligence-related technology R&D and product development, aiming to integrate both parties' technological strengths and improve embodied-intelligence robots' ability to understand and generalize across complex scenarios"
- National Social Security Fund (combinations 601, 502, and 109): 933,400 shares combined
- CNPC Kunlun Capital, China Southern Power Grid Industry-Finance Holdings, Tianyi Capital, and Tencent (Shanghai Qishan Investment): 903,290 shares each
- CITIC Securities Investment (sponsor concurrent investment): 808,900 shares, 24-month lock-up
- Employee Asset Management Plan No. 1 (executives): 1.3561 million shares, 12-month lock-up; Plan No. 2 (core employees): 444,300 shares, 36-month lock-up
- 2023: revenue 159 million yuan, net loss of 11.1451 million yuan
- 2024: revenue 393 million yuan, net profit 95.4747 million yuan (first profit)
- 2025: revenue 1.699 billion yuan, non-GAAP net profit 590 million yuan
- 2026 Q1: revenue ~423 million yuan (+68.49% YoY), non-GAAP net profit down YoY (heavy increases in R&D/sales expenses)
- 2026 H1 guidance: revenue 1.052-1.128 billion yuan (+35.62% to +45.41% YoY), net profit attributable to parent 258-306 million yuan
- Over 5,500 humanoid robots shipped in 2025
- Intelligent robot model R&D (the company says "nearly half" of funds, betting on both the WMA and VLA technical routes)
- Robot body (hardware) R&D
- New intelligent robot product development
- Intelligent robot manufacturing base construction
- IT之家, Aug 6: https://www.ithome.com/0/986/699.htm
- IT之家 prospectus summary: https://www.ithome.com/0/983/890.htm
- Securities Times, Aug 6, "Unitree IPO pricing revealed; DeepSeek among 9 strategic investors": https://www.stcn.com/article/detail/4062750.html
- Securities Times, Aug 6, "Unitree prices at 150.8 yuan; DeepSeek participates": https://www.stcn.com/article/detail/4062608.html
- Caijing, Aug 7, "Unitree's STAR Market IPO on August 10": https://gu.qq.com/resources/shy/news/detail-v2/index.html?id=SN20260807142246a6f93ac2
- Tencent News, Aug 8, "DeepSeek allocated Unitree IPO shares worth ~141 million yuan": https://new.qq.com/rain/a/20260808A04PE900
- Whether the 220x P/E can be justified depends on actual shipments and net profit delivery in H2 2026 - H1 2027
- The specific technical path of the DeepSeek-Unitree partnership (WMA vs VLA, primary vs secondary) is not disclosed in the announcement
- The valuation jump (12.7B -> 61B yuan) happened within one year, with no comparable anchor
- The prospectus shows 2026 Q1 non-GAAP net profit down YoY, indicating clear cost pressure during expansion
- The customer mix (ToB/ToG/ToC) and unit prices of the 5,500 humanoid robots shipped in 2025 are undisclosed
- The industry-average P/E of 38.56x (CSI Index Company classification) needs independent verification
- Overseas revenue share (North America, Europe, Southeast Asia) and FX risk are undisclosed
Strategic Investor Lineup
Nine strategic investors were allocated 8.089286 million shares in total. The most prominent is DeepSeek (Hangzhou DeepSeek AI Fundamental Technology Research Co., Ltd.):Other strategic investors:
Fundamentals
Use of Proceeds
Details Worth Expanding
The DeepSeek–Unitree strategic pairing is not ordinary financial investment. From the announcement's wording, Unitree intends to use DeepSeek as a model supplier — the "brain" of embodied intelligence via VLA/WMA, while building the "body" itself. DeepSeek's 36-month lock-up implies both sides are betting on 3+ years of technical coupling. This aligns with a broader domestic strategy of embodied-AI companies binding to leading LLM vendors: Agibot with its in-house Lingxi model, Galbot building its own models, and Unitree choosing DeepSeek.
A 219x P/E versus the 38.56x industry average is the market voting with its feet on the "first humanoid robot stock" concept premium. Comparable peers such as Leaderdrive, Estun, and Wuzhou Xinchun trade at 30-60x P/E; Unitree is roughly 6x that. Peers mostly have revenue in the tens of billions of yuan with 500 million - 1.5 billion yuan net profits, while Unitree's revenue is only 1.699 billion yuan — but with a visibly steeper growth curve. Whether the ~220x multiple holds depends on actual shipments and profit delivery after H1 2026.
Founder Wang Xingxing (born in the 1990s, started with quadruped robots from an academic project in 2016) shipped over 5,500 humanoid robots in 2025 — globally second only to Tesla Optimus (cumulative thousands in 2025, though Tesla has not published exact figures), and clearly ahead of Figure AI (~200-500 units in 2025), 1X Technologies (ramping production), and Apptronik (Apollo in production preparation).
Sources
Assessment
Unitree's STAR Market IPO is a landmark event marking China's embodied-AI/humanoid robot sector shifting from a "technology narrative" to a "capital narrative." The DeepSeek + Tencent + Social Security Fund + CNPC strategic roster reveals three signals: (1) national capital and internet capital are betting simultaneously; (2) model-body industrial-chain alliances are taking shape; (3) the valuation premium rests not on revenue scale but on expectations that the "first humanoid robot stock" narrative will be delivered. For unlisted peers such as Agibot, Galbot, Booster Robotics, and Robot Era, this is both an endorsement and pressure — the valuation benchmark for the next round has changed.